Xilio Therapeutics (XLO)
(Delayed Data from NSDQ)
$1.12 USD
+0.06 (5.66%)
Updated Jun 11, 2024 04:00 PM ET
After-Market: $1.12 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
F Value B Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/12/24 |
---|---|
Current Quarter | -0.23 |
EPS Last Quarter | -0.59 |
Last EPS Surprise | -96.67% |
ABR | 1.25 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.48 |
Next Year | -1.16 |
EPS (TTM) | -2.54 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 30.00M | NA | 30.00M | 75.00M |
# of Estimates | 1 | NA | 1 | 1 |
High Estimate | 30.00M | NA | 30.00M | 75.00M |
Low Estimate | 30.00M | NA | 30.00M | 75.00M |
Year ago Sales | 0.00M | 0.00M | NA | 30.00M |
Year over Year Growth Est. | NA | NA | NA | 150.00% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.23 | -0.41 | -1.48 | -1.16 |
# of Estimates | 2 | 2 | 3 | 3 |
Most Recent Consensus | 0.20 | -0.24 | -0.63 | 0.01 |
High Estimate | 0.20 | -0.24 | -0.63 | 0.01 |
Low Estimate | -0.66 | -0.57 | -2.16 | -1.89 |
Year ago EPS | -0.70 | -0.61 | -2.78 | -1.48 |
Year over Year Growth Est. | 67.14% | 32.79% | 46.76% | 21.62% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 1 | 1 |
Up Last 60 Days | 1 | 1 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 1 | 0 | 0 |
Down Last 60 Days | 1 | 1 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.23 | -0.41 | -1.48 | -1.16 |
7 Days Ago | -0.23 | -0.41 | -1.48 | -1.16 |
30 Days Ago | -0.48 | -0.43 | -1.53 | -1.18 |
60 Days Ago | -0.48 | -0.43 | -1.53 | -1.18 |
90 Days Ago | -0.26 | -0.26 | -1.89 | -1.73 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.23 | -0.41 | -0.63 | 0.01 |
Zacks Consensus Estimate | -0.23 | -0.41 | -1.48 | -1.16 |
Earnings ESP | 0.00% | 0.00% | 57.43% | 100.86% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.59 | -0.64 | -0.61 | -0.70 | NA |
Estimate | -0.30 | -0.62 | -0.76 | -0.84 | NA |
Difference | -0.29 | -0.02 | 0.15 | 0.14 | -0.01 |
Surprise | -96.67% | -3.23% | 19.74% | 16.67% | -15.87% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more